GGrantIndex
Sort

78,016 grants matching breast cancer

TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis

$909,583
Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2020 · CA

PRECISION THERAPY FOR THE ERADICATION OF BRAIN METASTATIC BREAST CANCER

$909,510
The Geneva Foundation · · FY2025 · Defense Health Agency

Ultrasound Imaging of Breast by Use of a Hemispheric Array and Inverse Scattering

$909,497
Robert C Waag · University Of Rochester · R01 · FY2011 · EB

Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA

$909,452
Miriam C Poirier · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Genetic Susceptibility for Breast Cancer Subtypes

$909,410
Andrew Olshan · Roswell Park Cancer Institute Corp · P01 · FY2014 · CA

(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'

$909,181
Lee W Jones · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

Genetic Epidemiology

$909,165
Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

The role of the ATM gene in familial breast cancer

$908,972
Georgia Chenevix-Trench · Queensland Institute Of Medical Research · R01 · FY2007 · CA

3D Bioprinted lung cancer models for drug screening

$908,895
Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer Research

$908,788
Xihong Lin · Harvard School Of Public Health · R35 · FY2023 · CA

Determining the Fate of Transmembrane Proteins

$908,652
Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Leadership, Planning and Evaluation (LP&E)

$908,501
Michael A Teitell · University Of California Los Angeles · P30 · FY2025 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$908,412
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

CANCER AND LEUKEMIA GROUP B CCOP RESEARCH BASE

$908,401
University Of Chicago · U10 · FY2001 · CA

Mechanisms of Normal Tissue Toxicity

$908,372
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

SOMATIC MUTATION RATE AS DETERMINANT OF BREAST CANCER PENETRANCE IN BRCA1/2 FAMILIAL CASES

$908,334
Rutgers, The State University Of New Jersey · · FY2019 · Defense Health Agency

Cancer and Context

$907,927
Ian G Macara · Vanderbilt University · R35 · FY2019 · CA

Pregnancy and Prenatal PAHs and other Environmental Exposures and Breast Cancer

$907,851
Mary Beth Terry · Columbia University Health Sciences · U01 · FY2016 · ES

Identifying driver mutations and tumor dependencies by comparative oncogenomics.

$907,845
Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2012 · CA

Tissue mechanics reprograms the tissue to malignancy and metastasis

$907,698
Valerie Marie Weaver · University Of California, San Francisco · R35 · FY2024 · CA

Systems Biology based Proteogenomic Translator for Cancer Marker Discovery towards Precision Medicine

$907,614
Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2020 · CA

Novel Markers for Disease Outcome in Breast Cancer

$907,363
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Directed Transport Physics and Muli-Scale Therapy of Colon Cancer Liver Metatasis

$907,219
Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2009 · CA

CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE

$907,206
California Family Health Council, Inc. · N01 · FY2013 · HD

CENTER FOR DEVELOPMENTAL AND MOLECULAR TOXICOLOGY

$907,200
University Of Wisconsin Madison · P30 · FY2000 · ES